Attitudes towards open‐label versus placebo‐control designs in oncology randomized trials: A survey of medical oncologists

RATIONALE, AIMS AND OBJECTIVES: Randomized trials are considered the gold standard when assessing the efficacy of new therapeutic agents. In clinical situations where no standard of care therapy is approved, randomized trials usually compare experimental agents to either a placebo or an open‐label n...

Descripción completa

Detalles Bibliográficos
Autores principales: Kushnir, Igal, Clemons, Mark, Fergusson, Dean, Bossé, Dominick, Reaume, Martin Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302988/
https://www.ncbi.nlm.nih.gov/pubmed/35191169
http://dx.doi.org/10.1111/jep.13669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302988/
https://www.ncbi.nlm.nih.gov/pubmed/35191169
http://dx.doi.org/10.1111/jep.13669

Ejemplares similares